Molecular Docking Analysis of Flavonoids from Verbascum Species Against Key Antidiabetic Targets: α-Glucosidase and Dipeptidyl Peptidase-IV (DPP-IV)

Eurasian Chemico-Technological Journal, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.18321/ectj1686
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Diabetes is one of the most significant global health challenges. With synthetic drugs causing side effects, researchers are turning to natural alternatives for prevention and treatment. This study used molecular docking to predict the interaction of flavonoids from Verbascum spp. and their affinity for binding to α-glucosidase (3WY1) and DPP-IV (5J3J) enzymes. Binding energies, hydrogen bond interactions, and hydrophobic contacts at the active sites were analyzed. Kaempferide stood out against α-glucosidase with the lowest binding energy (‒5.03 kcal/mol), forming strong hydrogen bonds to GLU231 (1.70 Å), LEU300 (1.95 Å), and ASN301 (2.00 Å). Luteolin 7-O-β-D-glucopyranoside showed weaker binding (‒3.37 kcal/mol) with bonds to GLU383 (1.88, 2.29 Å) and TRP394 (2.45 Å). For DPP-IV, luteolin had the best affinity (‒6.01 kcal/mol), creating five hydrogen bonds with GLY335 (1.92, 2.11 Å), SER277 (2.08 Å), TRP337 (2.82 Å), and SER275 (2.99 Å). These results position kaempferide and luteolin as promising candidates for developing natural antidiabetic agents from Verbascum species.